World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
41017
World Ranking
7621
National Ranking
3969

Overview

David B. Clifford is affiliated with Washington University in St. Louis in the United States. Their academic work spans extensively in the field of medicine, focusing particularly on infectious diseases, neurology, virology, epidemiology, and oncology. Over the course of their career, they have contributed to a wide range of research topics primarily linked to HIV treatment and complications, neurodegenerative diseases, and viral infections.

Key areas of research include:

  • HIV Research and Treatment
  • HIV-related health complications and treatments
  • Polyomavirus and related diseases
  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • HIV/AIDS Research and Interventions
  • Neuroinflammation and Neurodegeneration Mechanisms

The scientist has published notably in various peer-reviewed journals, with frequent venues including:

  • Alzheimer's & Dementia
  • UNC Libraries
  • Clinical Infectious Diseases
  • Neurology
  • Annals of Neurology

David B. Clifford has co-authored numerous papers alongside several key collaborators. The most frequent co-authors are:

  • Ronald J. Ellis
  • Scott Letendre
  • Christina M. Marra
  • Benjamin B. Gelman
  • Eric McDade

Recent scholarly works include the following publications:

  • Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease, 2020, Clinical Infectious Diseases
  • Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease, 2020, Arthritis Care & Research
  • Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease, 2020, Arthritis & Rheumatology
  • Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology, 2020, Neurology
  • Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors, 2022, Annals of Neurology

In addition to research articles, David B. Clifford has contributed to book publications, including a title published by the Royal Society of Chemistry:

  • Carbon Dioxide Electrochemistry, 2020

Best Publications

  • Updated research nosology for HIV-associated neurocognitive disorders

    A. Antinori;G. Arendt;J. T. Becker;B. J. Brew

  • HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

    R. K. Heaton;D. B. Clifford;D. R. Franklin;S. P. Woods

  • HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

    Robert K. Heaton;Donald R. Franklin;Ronald J. Ellis;J. Allen McCutchan

  • Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

    Scott Letendre;Jennifer Marquie-Beck;Edmund Capparelli;Brookie Best

  • Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

    Tarek A. Yousry;Eugene O. Major;Caroline Ryschkewitsch;Gary Fahle

  • Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

    David W Haas;Heather J Ribaudo;Richard B Kim;Camlin Tierney

  • PML diagnostic criteria: Consensus statement from the AAN neuroinfectious disease section

    Joseph R. Berger;Allen J. Aksamit;David B. Clifford;Larry Davis

  • Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

    David B Clifford;Andrea DeLuca;David M Simpson;Gabriele Arendt

  • HIV-associated neurocognitive disorder

    David B Clifford;Beau M Ances

  • HIV and aging: State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group

    Kevin P. High;Mark Brennan-Ing;David B. Clifford;Mardge H. Cohen

  • CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy.

    Ronald J. Ellis;Jayraan Badiee;Florin Vaida;Scott Letendre

  • The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures.

    D.B. Clifford;J.W. Olney;A. Maniotis;R.C. Collins

  • Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study

    Robert K. Heaton;Donald R. Franklin;Reena Deutsch;Scott Letendre

  • Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

    Christina M. Marra;Yu Zhao;David B. Clifford;Scott Letendre

  • Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

    Ludwig Kappos;David Bates;Gilles Edan;Mefkûre Eraksoy

  • Continued High Prevalence and Adverse Clinical Impact of Human Immunodeficiency Virus–Associated Sensory Neuropathy in the Era of Combination Antiretroviral Therapy: The CHARTER Study

    Ronald J. Ellis;Debralee Rosario;David B. Clifford;Justin C. McArthur

  • Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.

    Igor Grant;Donald R. Franklin;Reena Deutsch;Steven P. Woods

  • A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection

    J. C. McArthur;C. Yiannoutsos;D. M. Simpson;B. T. Adornato

  • Failure of Cytarabine in Progressive Multifocal Leukoencephalopathy Associated with Human Immunodeficiency Virus Infection

    Colin D. Hall;Urania Dafni;David Simpson;David Clifford

  • Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals

    David B. Clifford;Scott Evans;Yijun Yang;Edward P. Acosta

Frequent Co-Authors

Ronald J. Ellis
Ronald J. Ellis University of California, San Diego
Justin C. McArthur
Justin C. McArthur Johns Hopkins University School of Medicine
Igor Grant
Igor Grant University of California, San Diego
Benjamin B. Gelman
Benjamin B. Gelman The University of Texas Medical Branch at Galveston
Susan Morgello
Susan Morgello Icahn School of Medicine at Mount Sinai
Ann C. Collier
Ann C. Collier University of Washington
Scott Letendre
Scott Letendre University of California, San Diego
Robert K. Heaton
Robert K. Heaton University of California, San Diego
J. Allen McCutchan
J. Allen McCutchan University of California, San Diego
Donald Franklin
Donald Franklin University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a medical career but want to explore broader healthcare opportunities, online degrees can be a flexible and affordable option. Many students start with a health administration degree, opening doors to leadership roles in hospitals, clinics, or insurance companies.

For those aiming for advanced positions, the cheapest master's in healthcare administration programs offer cost-effective ways to specialize further and boost your earning potential. These programs focus on healthcare policy, management, and organizational leadership.

Thinking clinically? You might consider the most affordable online dnp programs to pursue advanced nursing roles, such as nurse practitioner or healthcare educator. Alternatively, if pharmacy interests you, there are options like a 3-year online pharmd for those seeking a fast-track to a Doctor of Pharmacy.

With so many paths available online, pursuing a medical or allied health career has never been more accessible or flexible.

Best Scientists Citing David B. Clifford

Trending Scientists

Recently Published Articles